Laurence Katznelson
Clinical Trials
- Recruiting Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
- Not Recruiting XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
- Not Recruiting An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies
- Recruiting Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults
- Not Recruiting A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome
- Not Recruiting Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly
- Not Recruiting XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors
- Not Recruiting Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT
Help
Trial Administration